Treatment Tolerance and Side Effects of Intraperitoneal Carboplatin and Dose-Dense Intravenous Paclitaxel in Ovarian Cancer.
CONCLUSION: Carboplatin IP and weekly IV paclitaxel was well-tolerated with a side-effect profile similar to or better than previously published traditional treatment regimens.
PMID: 30390943 [PubMed - in process]
Source: Journal of Obstetrics and Gynaecology Canada : JOGC - Category: OBGYN Tags: J Obstet Gynaecol Can Source Type: research
More News: Brain | Canada Health | Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Gastroenterology | Neurology | Neurosurgery | OBGYN | Ovarian Cancer | Ovaries | Pain | Thrombocytopenia | Toxicology